243 related articles for article (PubMed ID: 23300679)
21. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
22. DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma.
Landi MT; Baccarelli A; Tarone RE; Pesatori A; Tucker MA; Hedayati M; Grossman L
J Natl Cancer Inst; 2002 Jan; 94(2):94-101. PubMed ID: 11792747
[TBL] [Abstract][Full Text] [Related]
23. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.
Tucker MA; Halpern A; Holly EA; Hartge P; Elder DE; Sagebiel RW; Guerry D; Clark WH
JAMA; 1997 May; 277(18):1439-44. PubMed ID: 9145715
[TBL] [Abstract][Full Text] [Related]
24. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
Roush GC; Barnhill RL
Br J Cancer; 1991 Nov; 64(5):943-7. PubMed ID: 1931621
[TBL] [Abstract][Full Text] [Related]
25. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.
Hastrup N; Hou-Jensen K
APMIS; 1993 Nov; 101(11):845-50. PubMed ID: 8286092
[TBL] [Abstract][Full Text] [Related]
26. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
Risser J; Pressley Z; Veledar E; Washington C; Chen SC
J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
[TBL] [Abstract][Full Text] [Related]
27. Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives.
Albert LS; Rhodes AR; Sober AJ
J Am Acad Dermatol; 1990 Jan; 22(1):69-75. PubMed ID: 2298967
[TBL] [Abstract][Full Text] [Related]
28. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
Clark WH; Hood AF; Tucker MA; Jampel RM
Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
[TBL] [Abstract][Full Text] [Related]
29. A cohort study of melanoma in patients with dysplastic nevi.
Halpern AC; Guerry D; Elder DE; Trock B; Synnestvedt M
J Invest Dermatol; 1993 Mar; 100(3):346S-349S. PubMed ID: 8440922
[TBL] [Abstract][Full Text] [Related]
30. Lack of association between intraocular melanoma and cutaneous dysplastic nevi.
Taylor MR; Guerry D; Bondi EE; Shields JA; Augsburger JJ; Lusk EJ; Elder DE; Clark WH; Van Horn M
Am J Ophthalmol; 1984 Oct; 98(4):478-82. PubMed ID: 6486223
[TBL] [Abstract][Full Text] [Related]
31. Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma.
Melamed RD; Aydin IT; Rajan GS; Phelps R; Silvers DN; Emmett KJ; Brunner G; Rabadan R; Celebi JT
J Invest Dermatol; 2017 Apr; 137(4):905-909. PubMed ID: 27890785
[TBL] [Abstract][Full Text] [Related]
32. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain.
Ródenas JM; Delgado-Rodríguez M; Farinas-Alvarez C; Herranz MT; Serrano S
Am J Epidemiol; 1997 Jun; 145(11):1020-9. PubMed ID: 9169911
[TBL] [Abstract][Full Text] [Related]
33. Ocular findings in patients with dysplastic nevus syndrome. An update.
Rodriguez-Sains RS
Dermatol Clin; 1991 Oct; 9(4):723-8. PubMed ID: 1934647
[TBL] [Abstract][Full Text] [Related]
34. Parakeratosis and pagetoid melanocytosis in the evaluation of dysplastic nevi and melanoma.
Panah E; Tan TL; Yazdan P; Compres E; Khan A; Kim D; Benton S; Zhao J; Gerami P
Arch Dermatol Res; 2022 Mar; 314(2):159-165. PubMed ID: 33733299
[TBL] [Abstract][Full Text] [Related]
35. Natural history of dysplastic nevi.
Halpern AC; Guerry D; Elder DE; Trock B; Synnestvedt M; Humphreys T
J Am Acad Dermatol; 1993 Jul; 29(1):51-7. PubMed ID: 8315078
[TBL] [Abstract][Full Text] [Related]
36. The genetics of hereditary melanoma and nevi. 1998 update.
Greene MH
Cancer; 1999 Dec; 86(11 Suppl):2464-77. PubMed ID: 10630172
[TBL] [Abstract][Full Text] [Related]
37. Prediction of histologic melanocytic dysplasia from clinical observation.
Roush GC; Dubin N; Barnhill RL
J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
[TBL] [Abstract][Full Text] [Related]
38. Dysplastic nevi and other risk markers for melanoma.
Seykora J; Elder D
Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
[TBL] [Abstract][Full Text] [Related]
39. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population.
Augustsson A; Stierner U; Rosdahl I; Suurküla M
Acta Derm Venereol; 1991; 71(6):518-24. PubMed ID: 1685835
[TBL] [Abstract][Full Text] [Related]
40. [Nevi, sun and the risk of melanoma].
Snellman E; Koulu L; Rantanen T
Duodecim; 2002; 118(4):359-66; quiz 366, 401. PubMed ID: 12233040
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]